发明名称 Cyclosporin analogues for preventing or treating hepatitis C infection
摘要 The present invention relates to cyclosporin analogues having antiviral activity against HCV and useful in the treatment of HCV infections. More particularly, the invention relates to novel cyclosporin analogue compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds.
申请公布号 US9603895(B2) 申请公布日期 2017.03.28
申请号 US201514843119 申请日期 2015.09.02
申请人 Enanta Pharmaceuticals, Inc. 发明人 Or Yat Sun;Wang Guoqiang;Long Jiang;Gao Xuri
分类号 A61K38/00;C07K5/00;C07K7/00;C07K16/00;C07K17/00;A61K38/13;A61K31/7088;A61K38/21;A61K45/00;C07K7/52;A61K45/06;C07K7/64 主分类号 A61K38/00
代理机构 Elmore Patent Law Group, P.C. 代理人 Harlan Edgar W.;Elmore, Esq. Carolyn S.;Elmore Patent Law Group, P.C.
主权项 1. A method of producing a compound represented by Formula (4-8): wherein; R4 and R5 are independently selected from hydrogen, methyl, ethyl, allyl, propyl or isopropyl; and R6 is a) R11, where R11 is selected from: 1) Hydrogen;2) Deuterium;3) C1-C8 alkyl;4) Substituted C1-C8 alkyl;5) C2-C8 alkenyl;6) Substituted C2-C8 alkenyl;7) C2-C8 alkynyl;8) Substituted C2-C8 alkynyl;9) C3-C12 cycloalkyl;10) Substituted C3-C12 cycloalkyl;11) Aryl;12) Substituted aryl;13) Heterocycloalkyl;14) Substituted heterocycloalkyl;15) Heteroaryl; and16) Substituted heteroaryl; b) —C(O)OR11, where R11 is as previously defined; c) —C(O) R11, where R11 is as previously defined; d) —C(O)OCH2-T-R12, where T is —O— or —S— and R12 is selected from: a. C1-C8 alkyl;b. Substituted C1-C8 alkyl;c. C2-C8 alkenyl;d. Substituted C2-C8 alkenyl;e. C2-C8 alkynyl;f. Substituted C2-C8 alkynyl;g. C3-C12 cycloalkyl;h. Substituted C3-C12 cycloalkyl;i. Aryl;j. Substituted aryl;k. Heterocycloalkyl;l. Substituted heterocycloalkyl;m. Heteroaryl; orn. Substituted heteroaryl; e) —C(O)N(R13)(R14), where R13 and R14 are independently selected from R11 and R11 is as previously defined or R13 and R14 , together with the nitrogen atom to which they are attached, form a substituted or unsubstituted heterocycloalkyl; f) —C(O)SR11, R11 is as previously defined; g) —C(S)O R11,where R11 is as previously defined; h) —C(O)OCH2OC(O) R12, where R12 is as previously defined; i) —C(S)S R11, where R11 is as previously defined; j) R15,where R15 is selected from: a. —M—R11, where R11 is as previously defined and M is selected from: i. C1-C8 alkyl;ii. Substituted C1-C8 alkyl;iii. C2-C8 alkenyl;iv. Substituted C2-C8 alkenyl;v. C2-C8 alkynyl;vi. Substituted C2-C8 alkynyl;vii. C3-C12 cycloalkyl; andviii. Substituted C3-C12 cycloalkyl;b. —M—NR16R11, where R16 is R11 or R16 and R11 together with the nitrogen atom to which they are attached form a substituted or unsubstituted heterocycloalkyl, M is as previously defined;c. —M—S(O)mR11, where m =0, 1,or 2; M and R11 are as previously defined;d. —M—OR11, where M and R11 are as previously defined;e. —M—C(O) R11, where M and R11 are as previously defined;f. —M—OC(O) R12, where M and R12 are as previously defined;g. —M—OC(O)O R12, where M and R12 are as previously defined;h. —M—NR17C(O) R12, where R17 is R11, M and R12 are as previously defined;i. —MNR17C(O)O R12, where R17, M and R12 are as previously defined;j. —M—C(O)NR16 R11, where R16, M and R11 are as previously defined;k. —M—C(O)N(R16)—OR11, where R16, M and R11 are as previously defined;l. —M—OC(O)NR16 R11, where R16, M and R11 are as previously defined;m. —M—NR17C(O)NR16 R11, where M, R11, R16 are as previously defined or R16 and R11 together with the nitrogen atom to which they are attached form a substituted or unsubstituted heterocycloalkyl;n. —M—C(S)S R11, where M and R11 are as previously defined;o. —M—OC(S)S R12, where M and R12 are as previously defined;p. —M—NR17C(O)S R12, where M, R17 and R12 are as previously defined;q. —M—SC(O)NR16 R11, where M, R11 and R16 are as previously defined or R16 and R11 together with the nitrogen atom to which they are attached form a substituted or unsubstituted heterocycloalkyl;r. —M—CH═N—O R11, where M and R11 are as previously defined;s. —M—CH═N—NR16 R11 R16 are as previously defined or R16 and R11 together with the nitrogen atom to which they are attached form a substituted or unsubstituted heterocycloalkyl; said method comprising the steps of: (1) reacting a compound of Formula 1-3, with a reducing agent in a protic solvent; (2) reacting the product of step (1) with Fmoc-Cl in an aprotic solvent in the presence of an organic base to produce a compound of Formula (4-1), (3) contacting the compound of Formula (4-1) with an acid in a protic solvent; (4) reacting the product of step (3) with acetic anhydride in an aprotic solvent in the presence of a base, thereby producing a compound of Formula (4-2), (5) reacting the compound of Formula (4-2) with sodium methoxide in methanol to produce a compound of Formula (4-3). (6) reacting the compound of Formula (4-3) with a compound of Formula (4-4), in an aprotic solvent in the presence of a coupling reagent and a base to produce a compound of Formula (4-5), (7) reacting the compound of Formula (4-5) with an acid to produce a compound of Formula (4-6), (8) reacting the compound of Formula (4-6) with alkali in a protic solvent to produce a compound of Formula (4-7), (9) reacting the compound of Formula (4-7) with a coupling reagent and a base in an aprotic solvent, thereby producing the compound of Formula (4-8).
地址 Watertown MA US